What it sells
Automates MedTech and pharma compliance
Business model breakdown
Buyer: who owns the budget?
UnverifiedQA/RA (regulatory affairs), clinical affairs and post-market surveillance leads at MedTech and IVD manufacturers.
Trigger: what makes them buy now?
Compliance burden under FDA, EU MDR and IVDR for literature evaluation, regulatory monitoring, complaint handling and safety database monitoring.
Workflow: what inputs become what output?
AI-enabled literature evaluation, regulatory monitoring, complaint handling and safety-database monitoring, delivered with validation documentation (IEC 62304, ISO 13485 templates).
Economics: what it saves and how it charges
Software subscription; claims trusted by 200+ MedTech and IVD leaders, ISO 27001 and 21 CFR Part 11 compliant.
Distribution: how it reaches customers
Demo-led ("Book a Demo").
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-02-19 | Series A | €17M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.